bioAffinity Technologies, Inc. (BIAF)

USD 0.51

(9.09%)

Inventory Summary of bioAffinity Technologies, Inc.

  • bioAffinity Technologies, Inc.'s latest annual inventory in 2023 was 18.48 Thousand USD , up 233.65% from previous year.
  • bioAffinity Technologies, Inc.'s latest quarterly inventory in 2024 Q2 was 29.76 Thousand USD , up 213.78% from previous quarter.
  • bioAffinity Technologies, Inc. reported annual inventory of 5540.00 USD in 2022, down -92.29% from previous year.
  • bioAffinity Technologies, Inc. reported annual inventory of 71.84 Thousand USD in 2021, up 153.41% from previous year.
  • bioAffinity Technologies, Inc. reported quarterly inventory of 9487.00 USD for 2024 Q1, down -48.67% from previous quarter.
  • bioAffinity Technologies, Inc. reported quarterly inventory of 18.48 Thousand USD for 2023 Q4, up 86.56% from previous quarter.

Annual Inventory Chart of bioAffinity Technologies, Inc. (2023 - 2019)

Historical Annual Inventory of bioAffinity Technologies, Inc. (2023 - 2019)

Year Inventory Inventory Growth
2023 18.48 Thousand USD 233.65%
2022 5540.00 USD -92.29%
2021 71.84 Thousand USD 153.41%
2020 28.35 Thousand USD 0.0%
2019 - USD 0.0%

Peer Inventory Comparison of bioAffinity Technologies, Inc.

Name Inventory Inventory Difference
Aclaris Therapeutics, Inc. - USD -Infinity%
Applied DNA Sciences, Inc. 330.02 Thousand USD 94.399%
Aspira Women's Health Inc. 227 Thousand USD 91.857%
Biodesix, Inc. 1.4 Million USD 98.68%
BioNexus Gene Lab Corp. 1.13 Million USD 98.375%
bioAffinity Technologies, Inc. 18.48 Thousand USD 0.0%
Bionano Genomics, Inc. 22.89 Million USD 99.919%
CareDx, Inc 19.47 Million USD 99.905%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 7.94 Million USD 99.767%
DarioHealth Corp. 5.06 Million USD 99.635%
Exact Sciences Corporation 127.47 Million USD 99.985%
Fulgent Genetics, Inc. 5.82 Million USD 99.683%
Guardant Health, Inc. 61.94 Million USD 99.97%
ICON Public Limited Company 1.00 USD -1848300.0%
IDEXX Laboratories, Inc. 380.28 Million USD 99.995%
Illumina, Inc. 587 Million USD 99.997%
Intelligent Bio Solutions Inc. 777.53 Thousand USD 97.623%
iSpecimen Inc. - USD -Infinity%
Standard BioTools Inc. 20.53 Million USD 99.91%
MDxHealth SA 2.77 Million USD 99.335%
23andMe Holding Co. 12.46 Million USD 99.852%
Medpace Holdings, Inc. 1.00 USD -1848300.0%
Myriad Genetics, Inc. 20.1 Million USD 99.908%
Mainz Biomed B.V. 613.63 Thousand USD 96.988%
ENDRA Life Sciences Inc. 2.62 Million USD 99.295%
NeoGenomics, Inc. 24.15 Million USD 99.923%
Neogen Corporation 189.26 Million USD 99.99%
Inotiv, Inc. 56.1 Million USD 99.967%
Natera, Inc. 40.75 Million USD 99.955%
OpGen, Inc. 1.00 USD -1848300.0%
OPKO Health, Inc. 65.69 Million USD 99.972%
Psychemedics Corporation 1.00 USD -1848300.0%
Prenetics Global Limited 3.12 Million USD 99.409%
Prenetics Global Limited 3.12 Million USD 99.409%
Precipio, Inc. 384 Thousand USD 95.186%
Personalis, Inc. 5.66 Million USD 99.673%
RadNet, Inc. 1.00 USD -1848300.0%
Sera Prognostics, Inc. - USD -Infinity%
Sotera Health Company 51.98 Million USD 99.964%
Neuronetics, Inc. 8.09 Million USD 99.772%
Star Equity Holdings, Inc. 3.42 Million USD 99.46%
Star Equity Holdings, Inc. 3.42 Million USD 99.46%
Trinity Biotech plc 19.93 Million USD 99.907%
T2 Biosystems, Inc. 4.81 Million USD 99.616%
Twist Bioscience Corporation 32.06 Million USD 99.942%
Exagen Inc. 2.87 Million USD 99.356%